Mescaline and the Brain: New Imaging Research Reveals a Different Kind of Psychedelic

Mescaline and the Brain: What New Research Reveals

One of humanity’s oldest known psychedelics is finally meeting modern brain imaging. A new animal study suggests mescaline may alter sensory filtering and connectivity through a distinctive effect on the cerebellum.

Mescaline has been part of Indigenous ceremonial traditions for thousands of years. Yet compared with psilocybin and LSD, surprisingly little is known about what mescaline does across the brain.

A new study published in Neuroscience Bulletin is beginning to change that. Using functional magnetic resonance imaging, or fMRI, Northeastern University researchers examined how mescaline affected brain activity, communication between brain regions and responses to sensory information in awake rats.

Their findings point toward a psychedelic with a potentially distinct neurological signature. Mescaline reduced activity in parts of the cerebellum while, paradoxically, increasing connectivity between the cerebellum and several other areas of the brain. It also changed how the animals processed certain smells and sounds.

In plain English: mescaline may affect not only what the brain experiences, but how the brain decides which incoming sensations deserve attention.

That is fascinating. It is also early-stage animal research—not proof of a medical benefit in humans. Around here, we can be excited without putting the lab coat on backward.

What Is Mescaline?

Mescaline is a naturally occurring serotonergic psychedelic found in several cactus species, most famously peyote (Lophophora williamsii) and San Pedro (Echinopsis pachanoi). Chemically, mescaline is known as 3,4,5-trimethoxyphenethylamine.

Like other classic psychedelics, it interacts strongly with serotonin 5-HT2A receptors. Mescaline can produce changes in visual perception, cognition, emotion and a person’s sense of meaning or self. Its effects generally last longer than those associated with psilocybin.

Mescaline also occupies a cultural position that cannot be reduced to chemistry. Peyote has a deep history of sacred use among Indigenous peoples of North America, and it remains central to ceremonies of the Native American Church. Any modern discussion of mescaline should respect that living tradition rather than treating peyote as merely the psychedelic trend of the week.

In the United States, mescaline is federally classified as a Schedule I controlled substance. Federal law includes a narrow religious exemption for the ceremonial use of peyote by members of the Native American Church; that exemption does not amount to general legalization. Mescaline is not approved by the FDA as a treatment for any condition.

What Did the New Mescaline Study Examine?

The 2026 study, led by researchers at Northeastern University, used awake-rat fMRI to build what the authors describe as a comprehensive neurobiological profile of mescaline.

The study included 24 adult rats in its imaging experiments, divided evenly between mescaline and control groups and balanced by sex. A separate experiment involving 16 rats tested prepulse inhibition, a measure of sensory gating.

Researchers examined three major questions:

1. Which brain regions became more or less active after mescaline?
2. How did communication among different brain regions change?
3. Did mescaline change how the animals processed smell and sound?

Using awake animals matters because anesthesia can itself alter brain activity and connectivity. The researchers acclimated the rats to the imaging procedure in advance, although no animal model can recreate or report the subjective dimensions of a human psychedelic experience.

The Cerebellum May Be More Than the Brain’s Movement Center

The study’s most notable finding involved the cerebellum.

Many people learned that the cerebellum mainly coordinates movement, balance and posture. That description is not wrong, but it is incomplete. The cerebellum also participates in cognition and helps organize incoming sensory information.

Following mescaline administration, researchers observed reduced positive BOLD activity and increased negative BOLD activity concentrated largely in cerebellar regions. BOLD, short for blood-oxygen-level-dependent signaling, is an indirect fMRI measure associated with changes in neural activity.

The authors interpreted this pattern as cerebellar suppression or functional disruption. At the same time, resting-state scans showed increased connectivity across the brain, including stronger links between the cerebellum and regions such as the hippocampus, thalamus, somatosensory cortex and midbrain.

That combination sounds contradictory: less local activity, but more communication with other areas.

It may be less like switching off the cerebellum and more like changing how its filters operate. The brain region may become less orderly within itself while interacting more broadly with the rest of the brain.

Mescaline and Sensory Gating

Your nervous system is constantly flooded with information: sounds, smells, light, pressure, movement and signals from inside your body. If every signal received equal priority, daily life would feel like trying to hold a meeting inside a casino during a fire drill.

Sensory gating is one way the brain filters, prioritizes or suppresses information so that we can respond appropriately.

The Northeastern researchers tested this in two ways.

First, they presented an almond odor considered rewarding to the rats. Control animals showed the expected brain response, but mescaline-treated animals did not. This suggests that mescaline disrupted the normal processing of that smell.

Second, they used prepulse inhibition. Normally, a softer sound immediately before a loud sound reduces the startle response to the louder noise. Mescaline’s effects varied by sound frequency: filtering improved at 4 and 20 kilohertz but worsened at 12 kilohertz.

That frequency-specific result matters. It suggests mescaline did not simply turn sensory gating “on” or “off.” Instead, it altered the filter selectively.

The researchers propose that disrupted cerebellar filtering could allow less-processed sensory information to reach other brain networks, potentially contributing to altered perception. It is a compelling hypothesis, but it remains a hypothesis based on animal data.

How Could Mescaline Differ From Psilocybin and LSD?

Mescaline, psilocybin and LSD are often grouped together as classic serotonergic psychedelics. All three can activate 5-HT2A receptors and may produce overlapping subjective effects, including visual alterations and changes in cognition.

That does not mean they are interchangeable.

Earlier work from the same laboratory found different patterns of brain activation after LSD and psilocybin in rats. In the new study, the authors argue that mescaline’s pronounced cerebellar suppression, combined with global hyperconnectivity, distinguishes it from those compounds.

This is one of the study’s most useful lessons: shared receptor activity does not guarantee identical effects across the brain.

The psychedelic category is a family, not a photocopier. Compounds can arrive at superficially similar experiences through meaningfully different biological routes. Understanding those differences could eventually help researchers investigate why psychedelics differ in duration, sensory character, risks and possible clinical applications.

Does This Mean Mescaline Can Treat Mental Health Conditions?

No—not based on this study.

The research did not test patients, therapy or clinical outcomes. It did not show that mescaline treats post-traumatic stress disorder, depression, schizophrenia or any other condition. The study examined acute brain and behavioral effects in rats.

The authors note that sensory-gating differences and altered connectivity also appear in certain psychiatric conditions. That makes mescaline potentially useful as a research tool for studying perception and brain networks. It does not mean mescaline causes those disorders, recreates their full complexity or has been proven to treat them.

There is some modern human research on mescaline. A recent randomized, double-blind, placebo-controlled study in healthy participants found dose-dependent subjective effects alongside temporary increases in blood pressure, heart rate and body temperature. Even so, the human evidence base remains much smaller than the literature on psilocybin.

The next logical steps include human neuroimaging, careful dose-response studies and controlled clinical research. Until those studies are completed, therapeutic claims should remain possibilities to investigate—not conclusions dressed up for social media.

Why Mescaline Research Has Lagged Behind

Mescaline is hardly new. The scientific gap reflects history, regulation and practical obstacles more than a lack of cultural importance.

Its Schedule I status makes research difficult and expensive. Its long duration can complicate clinical protocols. Meanwhile, the modern psychedelic revival has concentrated heavily on psilocybin and, to a lesser extent, LSD and MDMA.

There is also an ethical issue specific to peyote. Wild peyote grows slowly and faces conservation pressure. Expanding scientific or popular interest must not encourage poaching, ecological harm or appropriation of Indigenous religious practices. Research into mescaline does not require turning a sacred and vulnerable cactus into a commodity.

Responsible psychedelic education means following the neuroscience while also paying attention to history, law, culture and ecology.

What This Research Really Tells Us

The most important takeaway is not that researchers have “solved” mescaline. They have identified a promising new question.

Mescaline may alter perception partly by changing how the cerebellum filters sensory information and communicates with the rest of the brain. The study also suggests that classic psychedelics should be investigated individually rather than assumed to work in identical ways.

For psychedelic science, that is real progress. Modern imaging is beginning to examine a substance whose ceremonial history reaches back thousands of years. But one rat fMRI study cannot explain the human experience, establish safety for an individual or demonstrate therapeutic effectiveness.

Curiosity brought us this far. Scientific humility is what gets us the rest of the way.

Frequently Asked Questions About Mescaline and the Brain

What does mescaline do to the brain?

Mescaline primarily acts as a serotonin 5-HT2A receptor agonist. The new animal research suggests it may suppress activity in parts of the cerebellum while increasing communication among broader brain networks and selectively altering sensory filtering.

Is mescaline the same as psilocybin?

No. Both are classic serotonergic psychedelics, but they are different compounds with different chemistry, duration and potentially distinct patterns of brain activity.

Was the new mescaline brain-imaging study conducted in humans?

No. The experiments used awake rats. The results can guide future research, but they cannot be assumed to describe the full human experience or prove a clinical benefit.

Is mescaline legal in the United States?

Mescaline is generally a Schedule I controlled substance under federal law. A narrow federal exemption protects qualifying ceremonial peyote use within the Native American Church. State laws and additional legal details can vary.

Is mescaline an FDA-approved treatment?

No. Mescaline is not approved by the FDA to treat any medical or mental health condition.

Why is the cerebellum important in this research?

Beyond coordinating movement, the cerebellum contributes to cognition and sensory processing. The study suggests that mescaline may disrupt its filtering role while increasing its communication with other brain regions.

The Learn Euphoria Perspective

At Learn Euphoria, our mission is legalization through education. That means discussing psychedelic research accurately, respecting the cultures connected to these substances and refusing to turn preliminary findings into medical promises.

The mescaline renaissance may be arriving more slowly than the psilocybin boom, but research like this shows why it deserves careful attention. One of the oldest known psychedelics may still have something genuinely new to teach neuroscience.

This article is for educational purposes only. It is not medical or legal advice and does not encourage the possession or use of controlled substances. Never change a medical treatment plan without consulting a qualified healthcare professional.